1997
DOI: 10.1007/s004310050562
|View full text |Cite
|
Sign up to set email alerts
|

A thyroxine dosage of 8 μg/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism

Abstract: Even though a subgroup of patients may require a higher dosage of L-thyroxine, an initial dosage of 7.5-8.0 micrograms/kg per day, with an early assessment of FT4, FT3, and TSH levels, is adequate for the treatment of the majority of infants with congenital hypothyroidism.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
25
0
2

Year Published

1999
1999
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(31 citation statements)
references
References 13 publications
4
25
0
2
Order By: Relevance
“…It has been argued that a delay in treatment could induce a loss in the potential of growth of the epiphyseal cartilage [18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28], which would agree with our findings. However, this should have no consequences nowadays as treatment is started much earlier.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…It has been argued that a delay in treatment could induce a loss in the potential of growth of the epiphyseal cartilage [18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28], which would agree with our findings. However, this should have no consequences nowadays as treatment is started much earlier.…”
Section: Discussionsupporting
confidence: 93%
“…5 and 12 years, puberty-related factors and treatment between 12 and 15 years were studied. Initial doses of LT4 have been largely studied elsewhere [7, 20, 21, 22, 23]and will not be mentioned further in this study.…”
Section: Introductionmentioning
confidence: 99%
“…Some authors [8]maintain that early normalization of serum T 4 levels, independent of the corresponding TSH concentrations, is a satisfactory treatment goal, whereas others [11, 12]have emphasized that the TSH level is the only biological marker of adequacy of tissue levels of T 4 , particularly in the brain. Proponents of management based on T 4 levels alone raise concerns about short-term side effects of overtreatment [8]and long-term neuropsychological sequelae [13], such as poor concentration with larger doses of T 4 .…”
Section: Discussionmentioning
confidence: 99%
“…Some studies suggest that an elevated TSH concentration is related to undertreatment only [9, 12, 14, 15], whereas other studies [8, 20, 25, 26]see an important role for variable maturation of the pituitary threshold for TSH release. Delayed maturation should only be implicated if TSH concentrations remain elevated despite appropriate T 4 replacement and T 4 levels in the upper range of normal [9].…”
Section: Discussionmentioning
confidence: 99%
“…Depending on the initial dose of L-T 4 , neonatal serum T 4 and thyrotrophin (TSH) levels may take several weeks to rise to the normal range. In the US (20) higher starting doses of L-T 4 (10-15 mg/kg per day) have been used to treat children with CH than in Europe (5,16,21) and have been associated with a shorter time to achieve euthyroidism. The Quebec group (9) reported that infants with severe CH, defined by low serum T 4 levels and retarded skeletal maturation, who had been treated with an initial dose of L-T 4 of 6 mg/kg per day beginning at a mean age of 5 weeks had a mean IQ at the age of 12 years that was 15 points lower than that of infants with less severe CH.…”
mentioning
confidence: 99%